Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$886K Buy
6,896
+170
+3% +$19.9K 0.25% 49
2026
Q1
$809K Buy
6,726
+90
+1% +$10.4K 0.26% 44
2025
Q4
$699K Buy
6,636
+796
+14% +$74.7K 0.22% 52
2025
Q3
$490K Buy
5,840
+3
+0.1% +$247 0.17% 67
2025
Q2
$462K Buy
5,837
+2,374
+69% +$189K 0.18% 65
2025
Q1
$311K Sell
3,463
-100
-3% -$9.34K 0.13% 80
2024
Q4
$354K Sell
3,563
-438
-11% -$45.2K 0.14% 67
2024
Q3
$454K Sell
4,001
-51
-1% -$6.06K 0.18% 59
2024
Q2
$502K Sell
4,052
-45
-1% -$5.8K 0.24% 45
2024
Q1
$541K Hold
4,097
0.27% 45
2023
Q4
$447K Hold
4,097
0.21% 45
2023
Q3
$422K Buy
4,097
+33
+0.8% +$3.56K 0.25% 46
2023
Q2
$469K Buy
4,064
+51
+1% +$5.79K 0.28% 44
2023
Q1
$427K Hold
4,013
0.27% 43
2022
Q4
$445K Buy
4,013
+220
+6% +$22.5K 0.33% 40
2022
Q3
$327K Hold
3,793
0.27% 44
2022
Q2
$346K Buy
3,793
+400
+12% +$35.5K 0.32% 41
2022
Q1
$278K Hold
3,393
0.19% 58
2021
Q4
$260K Buy
+3,393
New +$270K 0.17% 65
2021
Q2
$264K Sell
3,393
-163
-5% -$12.1K 0.18% 58
2021
Q1
$262K Hold
3,556
0.2% 52
2020
Q4
$278K Hold
3,556
0.22% 43
2020
Q3
$281K Buy
+3,556
New +$279K 0.27% 40

Other funds holding MRK

Planned Solutions's MRK Position: Q2 2026 in Review

Planned Solutions increased its Merck (MRK) stake by 2.5% in Q2 2026, buying an estimated $19.9K and bringing the position to 6,896 shares worth $886K. The position accounts for 0.25% of the portfolio, ranked #49.

Planned Solutions first reported a position in MRK in Q3 2020 and has held it in 23 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Planned Solutions held 6,896 shares of Merck worth $886K as of Q2 2026.
  • Planned Solutions bought 170 Merck shares in Q2 2026, an estimated $19.9K.
  • Merck made up 0.25% of Planned Solutions's portfolio in Q2 2026, its #49 holding.
  • Planned Solutions first reported a position in Merck in Q3 2020 and has held it in 23 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Planned Solutions's 13F filing for Q2 2026, filed 13 Jul 2026.